Last reviewed · How we verify

NCT06754215

Smoking Cessation Intervention Development for Homeless Youth

Recruiting now NA Last updated 7 February 2025
What this trial tests

NA trial testing Focus Group in Cigarette Smoking-Related Carcinoma in 298 participants. Currently enrolling.

Timeline
20 September 2017
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorOhio State University Comprehensive Cancer Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingnone
Primary purposeprevention
Enrollment298
Start date20 September 2017
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ohio State University Comprehensive Cancer Center

Who can join

Adults 14 to 24, any sex, with Cigarette Smoking-Related Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial develops a contextually tailored and optimized smoking cessation intervention and studies smoking motivations and motivations to quit smoking in homeless youth. Identifying motivations for smoking and motivations to quit smoking may help researchers build a program to help homeless young people quit smoking cigarettes if desired.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Focus Group

Trials testing the same drug.

Other recruiting trials for Cigarette Smoking-Related Carcinoma

Currently open trials in the same condition.

Other Ohio State University Comprehensive Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06754215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing